Agitation and Delirium at the End of Life: “We Couldn't Manage Him”
The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
Delirium is the most common neuropsychiatric complication experienced by patients with advanced illness, occurring in up to 85% of patients in the last weeks of life. Using the case of Mr L, a 59-year-old man with metastatic lung cancer who developed an agitated delirium in the last week of life, we review the evaluation and management of delirium near the end of life. Although some studies have identified agitation as a central feature of delirium in 13% to 46% of patients, other studies have found up to 80% of patients near the end of life develop a hypoactive, nonagitated delirium. Both the agitated (hyperactive) and nonagitated (hypoactive) forms of delirium are harbingers of impending death and are associated with increased morbidity in patients who are terminally ill, causing distress for patients, family members, and staff. Delirium is a sign of significant physiological disturbance, usually involving multiple causes, including infection, organ failure, and medication adverse effects. Often these causes of delirium are not reversible in the dying patient, and this influences the outcomes of its management. Delirium can also significantly interfere with the recognition and control of other physical and psychological symptoms, such as pain. Unfortunately, delirium is often misdiagnosed or unrecognized and thus inappropriately treated or untreated in terminally ill patients. To manage delirium in terminally ill patients, clinicians must be able to diagnose it accurately, undertake appropriate assessment of underlying causes, and understand the benefits and risks of the available pharmacological and nonpharmacological interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Clarifying Confusion: The Confusion Assessment Method: A New Method for Detection of Delirium
Inouye, S. K., van Dyck, C. H., Alessi, C. A., Balkin, S., Siegal, A. P., & Horwitz, R. I. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-941 · Cited by 5,250
A Multicomponent Intervention to Prevent Delirium in Hospitalized Older Patients
Inouye, S. K., Bogardus, S. T., Charpentier, P. A., Leo-Summers, L., Acampora, D., Holford, T. R., & Cooney, L. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400901 · Cited by 2,917 · cited 1×
“Interventions directed at constant orientation, correction of hearing and visual impairment, reversal of dehydration, and early mobilization appear to significantly reduce the number and duration of episodes of delirium in hospitalized older patients.(103) These preventive interventions might be adapted to the needs o…”
BackgroundSchneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
Reducing Delirium After Hip Fracture: A Randomized Trial
Marcantonio, E. R., Flacker, J. M., Wright, R. J., & Resnick, N. M. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49108.x · Cited by 1,361 · cited 4×
“aLevel of Evidence Use of these nonpharmacological interventions in the prevention of delirium has been shown to reduce its incidence (level I).(47,51) Use of these nonpharmacological interventions in the treatment of delirium has resulted in faster improvement of symptoms and of cognition scores without any effects o…”
BackgroundInfluentialRisk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications
Wang, P. S., Schneeweiss, S., Avorn, J., Fischer, M. A., Mogun, H., Solomon, D. H., & Brookhart, M. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052827 · Cited by 959 · cited 1×
“A second, retrospective study of nearly 23 000 older patients found higher mortality rates associated with typical than with atypical antipsychotics—whether or not they had dementia.(83) This finding led to an extension of the FDA warning to typical antipsychotics.”
BackgroundThe memorial delirium assessment scale
Breitbart, W., Rosenfeld, B., Roth, A., Smith, M. J., Cohen, K., & Passik, S. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(96)00316-8 · Cited by 846 · cited 1×
“The Memorial Delirium Assessment Scale has been validated in inpatient palliative care settings with a sensitivity of 97% and a specificity of 95% at a cutoff score of 7.(18,19)”
BackgroundOccurrence, Causes, and Outcome of Delirium in Patients With Advanced Cancer: A Prospective Study
Lawlor, P. G., Gagnon, B., Mancini, I. L., Pereira, J. L., Hanson, J., Suarez-Almazor, M. E., & Bruera, E. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.786 · Cited by 800 · cited 4×
“On palliative care units and in hospice settings, delirium is often a predictor of impending death in patients with advanced cancer.(4,5,43,44) Delirium presenting with hypoactive subtype, irreversible etiologies, and greater cognitive impairment is often associated with death within a period of days to weeks.”
BackgroundInfluentialMaltoni, M., Caraceni, A., Brunelli, C., Broeckaert, B., Christakis, N., Eychmueller, S., Glare, P., Nabal, M., Viganò, A., Larkin, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.866 · Cited by 664
Kalisvaart, K. J., De Jonghe, J. F. M., Bogaards, M. J., Vreeswijk, R., Egberts, T. C. G., Burger, B. J., Eikelenboom, P., & Van Gool, W. A. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53503.x · Cited by 647 · cited 1×
“However, it did reduce the severity and duration of delirium.(55) Whether such an approach would work with terminally ill patients is uncertain.”
Background
Cited by
Hosie, A., Davidson, P. M., Agar, M., Sanderson, C. R., & Phillips, J. (2013) · Palliative Medicine · doi:10.1177/0269216312457214 · Cited by 331
Hui, D., Frisbee-Hume, S., Wilson, A., Dibaj, S. S., Nguyen, T., De La Cruz, M., Walker, P., Zhukovsky, D. S., Delgado-Guay, M., Vidal, M., et al. (2017) · JAMA · doi:10.1001/jama.2017.11468 · Cited by 207
“Secondary outcomes defined a priori included (1) the severity of delirium assessed with the Memorial Delirium Assessment Scale (MDAS; range, 0-30; higher scores indicate greater severity) at baseline, 2, 4, and 8 hours and then daily until discharge, (2) the use of any additional psychotropic agents during the first 8…”
Depression and end-of-life care for patients with cancer
Rosenstein, D. L. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/drosenstein · Cited by 92
Metadata
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-12-24
- Volume
- 300
- Issue
- 24
- Pages
- 2898
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1505289992
- Cited by
- 212
- References
- 89
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.